Correction: Investigating Stem-like CD4 T Cells in Tumors: A New Perspective on Antitumor Immunity
-
By
-
Jiaxiang Xu
-
Yunchao Yang
-
Jun Zhang
-
Yue Zhang
-
September 14, 2026
Clinical Scorecard: Correction: Investigating Stem-like CD4 T Cells in Tumors: A New Perspective on Antitumor Immunity
At a Glance
| Category | Detail |
|---|
| Condition | Stem-like CD4 T Cells in Tumors |
| Key Mechanisms | Emerging framework for antitumor immunity |
| Target Population | Patients with tumors |
| Care Setting | Oncology and Immunology |
Key Highlights
- Correction of departmental designation
- Affiliation clarified to Affiliated Hospital of Shandong University of Traditional Chinese Medicine
- Focus on stem-like CD4 T cells in tumor immunity
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Patients with tumors
Focus on antitumor immunity mechanisms
Clinical Best Practices
Related Resources & Content
